Taiwan has ramped up production and imports of the main drug used to treat mycoplasma pneumoniae in children, amid a surge in cases of the respiratory illness reported in China in recent weeks, the Taiwan Food and Drug Administration (TFDA) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Jeremy Lin joins ESPN's NBA analyst lineup for new season
10/16/2026 10:53 AM - Business
U.S. dollar up sharply in Taipei trading
10/16/2026 10:22 AM - Society
Taiwan headline news
10/16/2026 10:19 AM - Business
Taiwan shares open higher
10/16/2026 09:11 AM - Politics
Cabinet approves upgraded dementia care plan targeting '888' goals by 2035
10/15/2026 09:03 PM